DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received a consensus recommendation of “Hold” from the ten research firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $65.00.
A number of research analysts have recently weighed in on the stock. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $68.00 target price for the company in a research report on Thursday, July 29th. TheStreet raised shares of DENTSPLY SIRONA from a “c+” rating to a “b” rating in a report on Thursday, August 5th. HC Wainwright cut their price objective on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “neutral” rating for the company in a report on Monday, August 9th. Finally, Barrington Research raised their price objective on shares of DENTSPLY SIRONA from $77.00 to $79.00 and gave the stock an “outperform” rating in a report on Friday, August 6th.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Harvest Fund Management Co. Ltd purchased a new stake in DENTSPLY SIRONA in the 1st quarter worth approximately $30,000. Liberty Wealth Management LLC purchased a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $33,000. Exchange Traded Concepts LLC purchased a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $36,000. First Command Bank purchased a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $38,000. Finally, Quadrant Capital Group LLC lifted its stake in DENTSPLY SIRONA by 40.3% in the 1st quarter. Quadrant Capital Group LLC now owns 651 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 187 shares in the last quarter. Institutional investors and hedge funds own 93.56% of the company’s stock.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, August 5th. The medical instruments supplier reported $0.71 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.06. DENTSPLY SIRONA had a net margin of 9.06% and a return on equity of 13.22%. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.01 billion. During the same period in the prior year, the firm earned ($0.18) EPS. The company’s revenue was up 117.3% compared to the same quarter last year. Equities analysts expect that DENTSPLY SIRONA will post 2.88 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 8th. Shareholders of record on Friday, September 24th will be paid a $0.11 dividend. This represents a $0.44 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend is Thursday, September 23rd. DENTSPLY SIRONA’s dividend payout ratio is presently 24.58%.
DENTSPLY SIRONA Company Profile
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
Read More: Inflation
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.